Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
Review Erowid at GreatNonprofits.org
Help us be a "Top Rated Nonprofit" again this year and spread
honest info (good or bad) about psychedelics & other psychoactive drugs.
("Share Your Story" link. Needs quick login creation but no verification of contact info)
DOB
Legal Status
by Erowid
U.S. FEDERAL LAW #
Caution :   All legal information should be verified through other sources. [see below]
U.S. FEDERAL LEGAL SUMMARY
DOB
REGULATED
Yes
STATUS
Scheduled
SCHEDULE
Schedule I
CLASSIFICATION
Hallucinogen
DOB is Schedule I in the United States. This means it is illegal to manufacture, buy, possess, or distribute (sell, trade or give) without a DEA license.

INTERNATIONAL LAW #
Australia #
Germany #
Listed in the BtMG in Anlaga I (list 1). See BtMG. (thanks L) (last updated Jul 2007)
New Zealand #
DOB is Schedule I (Class A) in New Zealand [reference]. DOB would also qualify as an "Analogue" under New Zealand's catch-all Analogues section in Schedule 3 / Class C of their drug laws that would make 2C-I, 2C-E, DOI, DOB, ephedrine, and pseudoephedrine Schedule 3 compounds in New Zealand. See for more information about this.
Poland #
DOB is controlled in Poland. See http://isap.sejm.gov.pl/DetailsServlet?id=WDU20111050614+2011%2406%2408&min=1. (thanks p) (last updated Aug 1 2011)
U.K. #
DOB is Schedule I/Class A in the U.K., making it illegal to sell, buy, or possess without a license.
If you have information about the legal status of this substance in any other country, please let us know.

CAUTION & DISCLAIMER #
Erowid legal information is a summary of data gathered from site visitors, government documents, websites, and other resources. We are not lawyers and can not guarantee the accuracy of the information provided here. We do our best to keep this information correct and up-to-date, but laws are complex and constantly changing. Laws may also vary from one jurisdiction to another (county, state, country, etc)...this list is not comprehensive.